American dermatology technology.

Skin barrier repairing expert.

Genepharm Biotech Corp. is mainly engaged in the development of skin topical products.

Dermatological technology originated in the Silicon Valley campus in San Francisco, USA, and was developed by the dermatology team from University of California, San Francisco (UCSF) and Stanford University (Stanford).

The core technical theory has been included in internationally renowned academic journals and textbooks. So far, Genepharm is still committed to developing better external use products.

Genepharm Biotech Corp. has successfully established three patented technology platforms for innovative formulations for external use:

Calcium-T: skin barrier regeneration and repair technology.

Aero-Foli: skin hair follicle transfer temperature-controlled foam formulation.

Gel-PAD: skin external drug sustained-release liquid membrane technology.

The three innovative technology platforms can be used for the development of various new dosage forms for external use. In the skin new drug part, it can be based on various skin indications, combining the main components of the drug can become a new dosage form drug with patent protection, such as human drugs, psoriasis, atopic dermatitis, or new antibacterial and analgesic pet drugs for external use.

Through three core technology platforms, Genepharm provides customers with more diverse, better quality and competitive skin topical products.

American dermatology technology.

Skin barrier repairing expert.

Genepharm Biotech Corp. is mainly engaged in the development of skin topical products.

Dermatological technology originated in the Silicon Valley campus in San Francisco, USA, and was developed by the dermatology team from University of California, San Francisco (UCSF) and Stanford University (Stanford).

The core technical theory has been included in internationally renowned academic journals and textbooks. So far, Genepharm is still committed to developing better external use products.

Genepharm Biotech Corp. has successfully established three patented technology platforms for innovative formulations for external use:

Calcium-T: skin barrier regeneration and repair technology.

Aero-Foli: skin hair follicle transfer temperature-controlled foam formulation.

Gel-PAD: skin external drug sustained-release liquid membrane technology.

The three innovative technology platforms can be used for the development of various new dosage forms for external use. In the skin new drug part, it can be based on various skin indications, combining the main components of the drug can become a new dosage form drug with patent protection, such as human drugs, psoriasis, atopic dermatitis, or new antibacterial and analgesic pet drugs for external use.

Through three core technology platforms, Genepharm provides customers with more diverse, better quality and competitive skin topical products.

Please call or fill out the form to contact us if you have any questions.

© 2020 Copyright - Genepharm Biotech Corp.
- made by bouncin